表現
全部

14.97%2026
2026
23.91%2025
2025
23.10%2024
2024
20.23%2023
2023
-29.28%2022
2022
40.50%2021
2021
66.84%2020
2020
66.8%0%-66.8%
Roman Hauk
I recently added to $SDLF.L (Standard Life PLC) as part of the income side of my portfolio, so I paid close attention to the latest H1 numbers. The headline looks ugly - a reported loss of about £203M. But the underlying picture is much better than that number suggests. Operating cash generation reached... 顯示更多 翻譯
Roman Hauk
Roman Hauk
斯洛伐克
$NOVO-B.CO (Novo Nordisk B A/S) and $TTE (TotalEnergies SE) both had news this week that I’m paying attention to, but for different reasons. Novo gave me both good and bad news almost at the same time. The STEP Young results were encouraging: after 68 weeks, 40.4% of children treated with semaglutide... 顯示更多 翻譯
Roman Hauk
Roman Hauk
斯洛伐克
I ran my own portfolio through the latest version of my Investor Alignment Score app, and the result was exactly what I hoped for - useful, honest, and not flattering for the sake of optics. My score came out at 64.76/100. The strongest areas were Accumulation 99.53/100, Leverage 100/100, and Position... 顯示更多 翻譯
Roman Hauk
Roman Hauk
斯洛伐克
This weekend I added a new section to my Investor Alignment Score tool Personal Income Diagnostics. Anyone on eToro can now upload their own eToro Account Statement, Excel or PDF, and get a private breakdown of their personal dividend income. It stays completely separate from the score itself and... 顯示更多 翻譯
Roman Hauk
Roman Hauk
斯洛伐克
I've just submitted my new Investor Alignment Score app to the eToro App Store for manual review. Instead of asking whether a portfolio is "good" or "bad," it checks whether an investor's actual behaviour matches the principles they claim to follow: long-term holding, DCA... 顯示更多 翻譯
Roman Hauk
Roman Hauk
斯洛伐克
I opened a small $500 position in $9926.HK (Akeso Inc) Akeso, about 0.37% of my portfolio. I’m treating it as another declared growth satellite alongside $ESTC (Elastic NV) and $BSP (Bending Spoons S.p.A), although with a much more catalyst-driven biotech profile. My portfolio remains built around... 顯示更多 翻譯
Roman Hauk
Roman Hauk
斯洛伐克
I like seeing two very different companies in my portfolio returning value to shareholders in two different ways. $3750.HK (Contemporary Amperex Technology Co Limited) CATL has announced an A-share buyback program worth up to CNY 40 billion, with the repurchased shares intended to be cancelled. That... 顯示更多 翻譯
Roman Hauk
Roman Hauk
斯洛伐克
Europe is heading into winter with gas storage lower than it would ideally like, while energy flows through the Middle East are still vulnerable. In my portfolio, this is not just a $TTE.PA (TotalEnergies SE) story. $TTE.PA is around 2.4% of the portfolio, but I also have exposure through $VAR.OL (Var... 顯示更多 翻譯
Roman Hauk
Roman Hauk
斯洛伐克
I reviewed Fidelity’s warning about debt increasingly financing the AI and data-center boom, but I am not changing my portfolio because of it. My core AI/software exposure is only around 7.5%, spread across names such as $ACN (Accenture Plc), $DOX (Amdocs Ltd), $NOW (ServiceNow Inc), $ADBE (Adobe Systems... 顯示更多 翻譯
Roman Hauk
Roman Hauk
斯洛伐克
I noticed something interesting when looking at the current eToro Discover rankings and then checking the same portfolio through a broader BullAware screen. On eToro, my profile is currently showing near the top of several Popular Investor lists, with a 2-year return of +54.97%, around 470 copiers... 顯示更多 翻譯

關於 Roman Hauk
斯洛伐克
策略: 收益策略

Dividend-focused long-term investor. DCA, income growth, and risk management.
显示完整個人簡介 翻譯
474 跟單者
46.4K 粉絲